» Articles » PMID: 28173869

Characteristics of Human Adipose Derived Stem Cells in Scleroderma in Comparison to Sex and Age Matched Normal Controls: Implications for Regenerative Medicine

Overview
Publisher Biomed Central
Date 2017 Feb 9
PMID 28173869
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adipose-derived stem cells (ADSCs) are emerging as an alternative stem cell source for cell-based therapies. Recent data suggest that autologous ADSC-enriched micrografting improves the effects of facial involvement in systemic sclerosis (SSc). We have extensively characterised ADSCs from SSc patients and compared their phenotype and function to healthy age- and sex-matched control ADSCs.

Methods: ADSCs were isolated and characterised from a cohort of six SSc patients (ADSC-SSc) and were compared to six healthy age- and sex-matched controls (ADSC-N). Cell surface phenotype lineage commitment was explored by flow cytometric analysis of mesenchymal and hematopoietic markers and by the capacity to differentiate to chondrogenic, osteogenic, and adipogenic lineages. Functional activities of ADSCs were assessed by biochemical and cellular assays for proliferation, metabolism, adhesion, morphology, migration, and invasion.

Results: Upon characterization of ADSC-SSc, we found that there was no alteration in the phenotype or surface antigen expression compared to healthy matched control ADSCs. We found that the differentiation capacity of ADSC-SSc was equivalent to that of ADSC-N, and that ADSC-SSc did not display any morphological or adhesive abnormalities. We found that the proliferation rate and metabolic activity of ADSC-SSc was reduced (p < 0.01). We found that the migration and invasion capacity of ADSC-SSc was reduced (p < 0.01) compared to healthy matched control ADSCs.

Conclusions: This study provides important findings that can differentially characterise ADSCs from SSc patients. Results indicate that the surface phenotype and differentiation capacity of ADSCs from SSc patients are identical to healthy matched ADSCs. While the findings indicate that the proliferation and migration capacity of ADSC-SSc is reduced, ADSC-SSc are capable of ex-vivo culture and expansion. These findings encourage further investigation into the understanding by which ADSCs can impact upon tissue fibrosis.

Citing Articles

Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight.

Avanoglu Guler A, Luca G, Dagna L, Matucci-Cerinic M, Campochiaro C Int J Mol Sci. 2024; 25(20).

PMID: 39457038 PMC: 11508720. DOI: 10.3390/ijms252011257.


Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications.

Kotani T, Saito T, Suzuka T, Matsuda S Inflamm Regen. 2024; 44(1):35.

PMID: 39026275 PMC: 11264739. DOI: 10.1186/s41232-024-00348-z.


Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.

Yang H, Cheong S, He Y, Lu F Stem Cell Res Ther. 2023; 14(1):372.

PMID: 38111001 PMC: 10729330. DOI: 10.1186/s13287-023-03543-w.


The Role of Box A of in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy.

Ei Z, Mutirangura A, Arunmanee W, Chanvorachote P In Vivo. 2023; 37(5):2006-2017.

PMID: 37652483 PMC: 10500522. DOI: 10.21873/invivo.13298.


Adipose derived stromal vascular fraction and fat graft for treating the hands of patients with systemic sclerosis. A randomized clinical trial.

Iglesias M, Torre-Villalvazo I, Butron-Gandarillas P, Rodriguez-Reyna T, Torre-Anaya E, Guevara-Cruz M PLoS One. 2023; 18(8):e0289594.

PMID: 37578960 PMC: 10424873. DOI: 10.1371/journal.pone.0289594.


References
1.
Bourin P, Bunnell B, Casteilla L, Dominici M, Katz A, March K . Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the.... Cytotherapy. 2013; 15(6):641-8. PMC: 3979435. DOI: 10.1016/j.jcyt.2013.02.006. View

2.
Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L . EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009; 68(5):620-8. DOI: 10.1136/ard.2008.096677. View

3.
Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove C, Bovenkerk J . Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109(10):1292-8. DOI: 10.1161/01.CIR.0000121425.42966.F1. View

4.
Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R . Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford). 2006; 46(3):403-8. DOI: 10.1093/rheumatology/kel267. View

5.
ZuK P, Zhu M, Ashjian P, De Ugarte D, Huang J, Mizuno H . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13(12):4279-95. PMC: 138633. DOI: 10.1091/mbc.e02-02-0105. View